← Leaderboards
Jordan J. Elm
University Of Cincinnati
$18,295,806
Attributed
$67,052,538
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $24M · FY2013–25$25M$18.8M$12.5M$6.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$96,387,606 · 8
By mechanism
U01$70,892,768 · 5
OT2$12,112,868 · 1
UH3$8,271,650 · 1
UG3$5,110,320 · 1
Top collaborators
- Catherine R. Dillon6 shared
- Wenle Zhao6 shared
- Joseph Paul Broderick5 shared
- J. Donald Easton5 shared
- James C Grotta5 shared
- S. Claiborne Johnston5 shared
- Pooja Khatri5 shared
- Eva Mistry5 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Pooja Khatri$21,577,634
- Joseph Paul Broderick$95,619,410
- Dawn O Kleindorfer$13,998,321
- James C Grotta$18,042,423
- Mathew Flathery$3,497,315
Others in their field
Top investigators on “National Institute Of Neurological Disorders And Stroke”
- Merit E Cudkowicz · Massachusetts General Hospital$59,335,976
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,240,903
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Joseph Paul Broderick · University Of Cincinnati$44,274,899
- Natalia S Rost · Massachusetts General Hospital$44,101,804
- Bradley F Boeve · Mayo Clinic Rochester$43,635,532
Research focus
National Institute Of Neurological Disorders And StrokeStrokeAcuteClinical TrialsInnovationSiteMedicalEnrollmentRandomizedImageTrial DesignCessation Of LifeHourData ManagementCaringCollaborationsIschemic StrokeDesignStroke TherapyPharmaceutical PreparationsReportingResearch PersonnelSouth CarolinaBrain Hemorrhage
Grant awards (26)
StrokeNet Thrombectomy Endovascular Platform (STEP)$8,852,633
OT2 · FY2025 · NS · contact PI
Strategy for Improving Stroke Treatment Response (SISTER) Trial$4,963,344
UH3 · FY2025 · NS
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$4,412,639
U01 · FY2025 · NS
Stroke Trials Network National Data Management Center (NDMC)$1,280,497
U01 · FY2025 · NS · contact PI
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$4,827,459
U01 · FY2024 · NS
Strategy for Improving Stroke Treatment Response (SISTER) Trial$3,308,306
UH3 · FY2024 · NS
StrokeNet Thrombectomy Endovascular Platform (STEP)$2,949,824
OT2 · FY2024 · NS · contact PI
Stroke Trials Network National Data Management Center (NDMC)$1,454,897
U01 · FY2024 · NS · contact PI
Making Acute Stroke Trials Succeed: Challenges and Potential Solutions$56,700
U01 · FY2024 · NS
Strategy for Improving Stroke Treatment Response (SISTER) Trial$5,110,320
UG3 · FY2023 · NS
NIH StrokeNet National Data Management Center (NDMC)$1,022,720
U01 · FY2022 · NS · contact PI
StrokeNet Thrombectomy Endovascular Platform (STEP)$310,411
OT2 · FY2022 · NS · contact PI
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$5,130,446
U01 · FY2021 · NS
NIH StrokeNet National Data Management Center (NDMC)$1,038,812
U01 · FY2021 · NS · contact PI
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$6,472,265
U01 · FY2020 · NS
NIH StrokeNet National Data Management Center (NDMC)$1,054,812
U01 · FY2020 · NS · contact PI
NIH StrokeNet National Data Management Center (NDMC)$1,077,384
U01 · FY2019 · NS · contact PI
Established Status Epilepticus Treatment Trial (ESETT) - SDMC$501,265
U01 · FY2018 · NS · contact PI
POINT: PLATELET-ORIENTED INHIBITION IN NEW TIA$11,826,732
U01 · FY2017 · NS
ConProject-001$11,705,995
U01 · FY2017 · NS
Established Status Epilepticus Treatment Trial (ESETT) - SDMC$489,198
U01 · FY2017 · NS · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$3,434,132
U01 · FY2016 · NS
Established Status Epilepticus Treatment Trial (ESETT) - SDMC$488,097
U01 · FY2016 · NS · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$7,772,710
U01 · FY2015 · NS
Established Status Epilepticus Treatment Trial (ESETT) - SDMC$544,514
U01 · FY2014 · NS · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$6,301,494
U01 · FY2013 · NS